Home › NDC Lookup › RxCUI directory › RxCUI 1251499

84 HR estradiol 0.00208 MG/HR / norethindrone acetate 0.0104 MG/HR Transdermal System — RxCUI 1251499

RxNorm drug concept · Semantic clinical drug
RxCUI 1251499 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1251499
Official name84 HR estradiol 0.00208 MG/HR / norethindrone acetate 0.0104 MG/HR Transdermal System
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asestradiol 0.00208 MG / norethindrone acetate 0.0104 MG per HR 84 HR Transdermal Patch; estradiol 50 MCG / norethindrone acetate 250 MCG/Day Twice Weekly Transdermal System; estradiol 0.05 MG / norethindrone acetate 0.25 MG per Day Twice Weekly Transdermal Patch
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)24,746 prescriptions · 43 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Norethindrone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Most norethindrone tablets — including brands like Camila, Errin, Emzahh, and Affodel — are progestin-only birth control pills taken daily to prevent pre...
  • Regular combination birth control pills contain two hormones — estrogen and progestin. Norethindrone is a progestin-only pill, sometimes called the 'mini-pill.' Because it has no e...
  • How is this different from regular birth control pills?
  • The most common thing people notice is irregular bleeding — spotting between periods, or changes in your cycle. Headache, breast tenderness, nausea, and dizziness are also reported...
📖 Read our full Norethindrone guide →

🕸️ Concept Web — How 84 HR estradiol 0.00208 MG/HR / norethindrone ac... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 84 HR estradiol 0.00208 MG/HR / norethindrone acetate 0.0104 MG/HR Transdermal System RxCUI 1251499

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Estradiol 4083
    • Norethindrone 7514
    • Estradiol / norethindrone 214551
    • Norethindrone acetate 31983
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Combipatch 216161
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Estradiol / norethindrone Transdermal System 1806052
    • Estradiol / norethindrone acetate Transdermal System 2648066
    • Estradiol / norethindrone Topical Product 1165174
    • Estradiol / norethindrone Transdermal Product 1295555
    • Estradiol / norethindrone acetate Topical Product 2662946
    • Estradiol / norethindrone acetate Transdermal Product 2662381
    • Estradiol / norethindrone Transdermal System [Combipatch] 1806054
    • Estradiol / norethindrone acetate Transdermal System [Combipatch] 2656767
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Estradiol 0.00208 MG/HR SCDC · 331469
  • Norethindrone acetate 0.0104 MG/HR SCDC · 1251498
  • Estradiol / norethindrone Transdermal System SCDF · 1806052
  • Estradiol / norethindrone acetate Transdermal System SCDFP · 2648066
  • Estradiol / norethindrone Topical Product SCDG · 1165174
  • Estradiol / norethindrone Transdermal Product SCDG · 1295555
  • Estradiol / norethindrone acetate Topical Product SCDGP · 2662946
  • Estradiol / norethindrone acetate Transdermal Product SCDGP · 2662381

Brand-Name Concepts

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1251499 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68968-0514-08 8 POUCH in 1 CARTON (68968-0514-8) / 1 PATCH in 1 POUCH / 3... CombiPatch (estradiol/norethindrone acetate transdermal system) Noven Therapeutics, LLC 1998-08-07
68968-0525-08 8 POUCH in 1 CARTON (68968-0525-8) / 1 PATCH in 1 POUCH / 3... CombiPatch (estradiol/norethindrone acetate transdermal system) Noven Therapeutics, LLC 1998-08-07
Observed labelers: Noven Therapeutics, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.